NEW YORK (GenomeWeb News) – Covaris announced today that it has signed a co-marketing deal with Illumina related to sequencing sample preparation.
Under the agreement, the firms will co-market Covaris' DNA shearing technologies with Illumina's next-generation sequencing product lines including the HiSeq, HiScanSQ, and Genome Analyzer.
According to Woburn, Mass.-based Covaris, its technology "enables higher recoveries for nucleic acid extraction, tissue homogenization, chromatin shearing, protein digestion, and cell lysis." It also is isothermal and non-contact, which ensures molecular stability.
Financial and other terms of the alliance were not disclosed.